Page 52 - Read Online

Singh et al. Cancer Drug Resist. 2025;8:56 Page 17 of 20

55. Velpula T, Buddolla V. Enhancing detection and monitoring of circulating tumor cells: integrative approaches in liquid biopsy advances.
J Liq Biopsy. 2025;8:100297. DOI PubMed PMC
56. Ren F, Fei Q, Qiu K, Zhang Y, Zhang H, Sun L. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation. J Exp
Clin Cancer Res. 2024;43:96. DOI PubMed PMC
57. Gao Y, Li C, Ji T, Yu K, Gao X. The biological function and mechanism of action of circRNA as a potential target in colorectal cancer.
Crit Rev Oncol Hematol. 2025;213:104828. DOI PubMed
58. Zhang Z, Yang T, Xiao J. Circular RNAs: promising biomarkers for human diseases. EBioMedicine. 2018;34:267-74. DOI PubMed
PMC
59. Connal S, Cameron JM, Sala A, et al. Liquid biopsies: the future of cancer early detection. J Transl Med. 2023;21:118. DOI PubMed
PMC
60. Feng XY, Zhu SX, Pu KJ, Huang HJ, Chen YQ, Wang WT. New insight into circRNAs: characterization, strategies, and biomedical
applications. Exp Hematol Oncol. 2023;12:91. DOI PubMed PMC
61. Alimohammadi M, Kahkesh S, Khoshnazar SM, et al. Circular RNAs and doxorubicin resistance in cancer: molecular mechanisms and
potential treatment targets. Gene. 2025;964:149636. DOI PubMed
62. Siavashy S, Soltani M, Rahimi S, Hosseinali M, Guilandokht Z, Raahemifar K. Recent advancements in microfluidic-based biosensors
for detection of genes and proteins: applications and techniques. Biosens Bioelectron X. 2024;19:100489. DOI
63. Latifi-Pakdehi T, Khezrian A, Doosti-Irani A, Afshar S, Mahdavinezhad A. Investigating the biomarker value of circRNAs in the
diagnosis of colorectal cancer: a systematic review. Discov Oncol. 2024;15:734. DOI PubMed PMC
64. Rashid S, Sun Y, Ali Khan Saddozai U, et al. Circulating tumor DNA and its role in detection, prognosis and therapeutics of
hepatocellular carcinoma. Chin J Cancer Res. 2024;36:195-214. DOI PubMed PMC
65. Luo YH, Yang YP, Chien CS, et al. Circular RNA hsa_circ_0000190 facilitates the tumorigenesis and immune evasion by upregulating
the expression of soluble PD-L1 in non-small-cell lung cancer. Int J Mol Sci. 2021;23:64. DOI PubMed PMC
66. Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018;17:160. DOI PubMed PMC
67. Wang X, Zhang H, Yang H, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the
miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14:539-55. DOI PubMed PMC
68. Huang X, Li Z, Zhang Q, et al. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198
suppression. Mol Cancer. 2019;18:71. DOI PubMed PMC
69. Dong ZR, Ke AW, Li T, et al. CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular
carcinoma progression and sorafenib treatment sensitivity. Mol Cancer. 2021;20:75. DOI PubMed PMC
70. Salami R, Salami M, Mafi A, Vakili O, Asemi Z. Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms. Cell
Commun Signal. 2022;20:13. DOI PubMed PMC
71. Weidle UH, Birzele F. Deregulated circRNAs in epithelial ovarian cancer with activity in preclinical in vivo models: identification of
targets and new modalities for therapeutic intervention. Cancer Genomics Proteomics. 2024;21:213-37. DOI PubMed PMC
72. Zhu Q, Zhang Y, Li M, et al. MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and
intracellular PI3K/AKT signaling. Biomark Res. 2023;11:1. DOI PubMed PMC
73. Xu A, Zhu L, Yao C, Zhou W, Guan Z. The therapeutic potential of circular RNA in triple-negative breast cancer. Cancer Drug Resist.
2024;7:13. DOI PubMed PMC
74. Li T, Wang WC, McAlister V, Zhou Q, Zheng X. Circular RNA in colorectal cancer. J Cell Mol Med. 2021;25:3667-79. DOI PubMed
PMC
75. Cai X, Nie J, Chen L, Yu F. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2
expression. Mol Genet Genomic Med. 2020;8:e1093. DOI PubMed PMC
76. Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 2017;66:1151-64. DOI PubMed
77. Kong Z, Wan X, Lu Y, et al. Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p. J Cell Mol
Med. 2020;24:799-813. DOI PubMed PMC
78. Yang F, Liu DY, Guo JT, et al. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol.
2017;23:8345-54. DOI PubMed PMC
79. Morena D, Picca F, Taulli R. CircNT5E/miR-422a: a new circRNA-based ceRNA network in glioblastoma. Transl Cancer Res.
2019;8:S106-9. DOI PubMed PMC
80. Zeng XY, Yuan J, Wang C, et al. circCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate
BRD4 signals. Mol Med. 2020;26:70. DOI PubMed PMC
81. Su Y, Feng W, Shi J, Chen L, Huang J, Lin T. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway.
Mol Cancer. 2020;19:23. DOI PubMed PMC 45